Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2015.0203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Therapy for Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2006English

Immunodivergence in Metastatic Colorectal Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Tumour-Infiltrating Neutrophils Counteract Anti-Vegf Therapy in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

A Plasma Cytokine and Angiogenic Factor (CAF) Analysis for Selection of Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer

Scientific Reports
Multidisciplinary
2015English

Xeloda as First-Line Therapy of Metastatic Colorectal Cancer-Our Experience

Archive of Oncology
OncologyHematology
2002English

Rechallenge Therapy and Treatment Holiday: Different Strategies in Management of Metastatic Colorectal Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2013English

Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice

Clinical Colorectal Cancer
OncologyGastroenterology
2019English

First-Line Therapy for Metastatic Colorectal Cancer: Current Perspectives and Future Directions

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Impact of Systemic Therapy on Circulating Leukocyte Populations in Patients With Metastatic Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy